Brimonidine
  
Side effects 
	
		
Options: 
			
			Hide MedDRA Preferred Terms
			
		
	
	
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | 
|  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 
| Endophthalmitis | Ocular hyperaemia | 7.7% - 24.8% |  |  |  |  |  |  | x | x | x | x | x | x | x |  |  |  |  |  | 
| Ocular hyperaemia | Ocular hyperaemia | 7.7% - 24.8% |  |  |  |  |  |  | x | x | x | x | x | x | x |  |  |  |  |  | 
| Eye redness |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  | 
| Conjunctival hyperaemia | Conjunctival hyperaemia | 18.2% |  |  |  |  | x | x |  |  |  |  |  |  |  | x | x | x | x | x | 
| Pain | Stinging | common — 7.1% - 35.5% |  |  |  |  | x |  | x | x | x | x | x | x | x | x | x | x | x | x | 
| Pain | 2.6% - 5.1% |  |  |  |  |  |  |  | x | x | x | x | x | x |  |  |  |  |  | 
| Somnolence | Drowsiness | very common, 1% - 15.2% |  |  |  | x |  | x | x | x | x | x | x | x | x |  |  |  |  |  | 
| Somnolence | postmarketing — 55% |  |  |  |  | x |  | x |  |  |  | x | x | x | x | x | x | x | x | 
| Asthenia | Fatigue | very common, 1% - 15.2% |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Asthenia | common, 1.6% |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Fatigue | Fatigue | very common, 1% - 15.2% |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Hyperaemia | Hyperaemia | common, very common |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  | 
| Headache | Headache | very common, 2.4% - 17% |  | x | x |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Conjunctivitis allergic | Conjunctivitis allergic | common, 9.2% |  |  |  |  | x | x |  |  |  |  |  |  |  | x | x | x | x | x | 
| Dry mouth | Dry mouth | very common, 1% - 21% |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Sensation of foreign body | Sensation of foreign body | common — 0% - 15.5% |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Pruritus | Pruritus | postmarketing — 1% - 9.8% |  |  | x |  |  |  | x | x | x | x | x | x | x | x | x | x |  |  | 
| Eye pruritus | Eye pruritus | common, 8.2% |  |  |  |  | x | x |  |  | x | x |  |  |  |  |  |  | x | x | 
| Vision blurred | Vision blurred | 0% - 18% |  | x |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Vital dye staining cornea present | Corneal staining | 4.1% - 9.2% |  |  |  |  |  |  |  |  | x | x | x | x | x |  |  |  |  |  | 
| Conjunctival follicles | Conjunctival follicles | very common, 1% - 8.5% |  |  |  |  |  |  | x |  | x | x | x | x | x |  |  |  |  |  | 
| Visual impairment | Visual disturbance | common, 6.1% |  |  |  |  | x | x |  |  |  |  |  |  |  | x | x | x | x | x | 
| Abnormal vision |  |  |  |  |  |  |  | x | x | x | x | x | x | x |  |  |  |  |  | 
| Eye irritation | Burning sensation in eye | 5.3% |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  | 
| Eye irritation | common — 1.6% |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Oedema | Oedema | common |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  | 
| Nasopharyngitis | Nasopharyngitis | 5% |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Common cold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | 
| Rosacea | Rosacea | 5% |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Conjunctival oedema | Conjunctival oedema | common, 1.3% - 6.3% |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Lacrimation increased | Lacrimation | common |  |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Lacrimation increased | common, 2.6% |  |  |  |  | x | x |  |  |  |  |  |  |  | x | x | x | x | x | 
| Gastrointestinal disorder | Gastrointestinal symptom NOS | common |  |  |  |  |  |  | x | x | x | x | x | x | x |  |  |  |  |  | 
| Gastrointestinal disorder | rare |  |  | x |  |  |  | x |  |  |  |  |  |  | x | x | x | x | x | 
| Intraocular pressure increased | Intraocular pressure increased | 4% |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Eye pain | Eye pain | common, 1.8% |  |  |  | x | x | x | x |  |  |  |  |  |  | x | x | x | x | x | 
| Ocular stinging |  |  |  |  |  |  | x |  |  | x | x |  |  |  |  |  |  |  |  | 
| Blepharitis | Blepharitis | common, 1.6% |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Photophobia | Photophobia | common, 0.5% - 8.4% |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 
| Dry eye | Dry eye | common, 2.9% |  |  |  |  | x | x |  |  |  |  |  |  |  | x | x | x | x | x | 
| Keratoconjunctivitis sicca | postmarketing |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | 
| Dizziness | Dizziness | uncommon, common |  |  |  | x | x |  | x | x | x | x | x | x | x | x | x | x | x | x | 
| Syncope | very rare, postmarketing |  |  |  |  |  |  | x |  |  |  | x | x | x |  |  |  |  | x | 
| Flushing | Flushing | 0% - 10% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Eyelid oedema | Eyelid oedema | common, 2.1% |  |  | x |  | x | x |  | x | x | x | x | x | x | x | x | x | x | x | 
| Erythema of eyelid | Erythema of eyelid | 0% - 5.2% |  |  |  |  |  | x |  | x | x | x | x | x | x | x | x | x | x | x | 
| Skin burning sensation | Skin burning sensation | 0.604% - 4% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Conjunctivitis | Follicular conjunctivitis | common, 1.3% |  |  |  |  | x | x |  |  |  |  |  |  |  | x | x | x | x | x | 
| Conjunctivitis | uncommon |  |  |  |  | x |  | x |  |  |  |  |  | x | x | x | x | x | x | 
| Blepharoconjunctivitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Conjunctival discharge |  |  |  |  |  |  |  |  | x | x | x | x | x | x |  |  |  |  |  | 
| Punctate keratitis | Punctate keratitis | common, 1.3% |  |  |  |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  | 
| Superficial punctate keratopathy |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Eye discharge | Eye discharge | common, 1.3% |  |  |  |  | x | x |  |  |  |  |  |  |  | x | x | x | x | x | 
| Rhinitis | Rhinitis | 1.1% |  |  |  |  | x | x |  |  |  |  |  |  |  | x | x | x | x | x | 
| Common cold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | 
| Erythema | Erythema | postmarketing — 0.906% - 8% |  | x |  |  | x |  |  |  |  |  |  |  |  |  | x |  |  | x | 
| Skin warm | 0% - 0.909% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Erythema facial |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Dermatitis | Dermatitis | 0.302% - 0.909% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Rash | postmarketing |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | 
| Dermatitis contact | Dermatitis contact | 0.302% - 0.909% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Allergic contact dermatitis |  |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Arrhythmia | Arrhythmia | uncommon |  |  |  |  |  |  | x |  |  |  | x | x | x |  |  |  |  |  | 
| Depression | Depression | uncommon |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  | 
| Dysgeusia | Dysgeusia | uncommon |  |  |  |  | x |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Hypertrophy | Hypertrophy | uncommon |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Palpitations | Palpitations | uncommon |  |  |  |  |  |  | x | x | x | x | x | x | x |  |  |  |  |  | 
| Pharyngitis | Pharyngitis | uncommon |  |  |  |  | x |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Nasal dryness | Nasal dryness | uncommon |  |  |  |  |  |  | x | x | x | x | x | x | x | x | x | x | x | x | 
| Eye oedema | Eye oedema | uncommon |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Skin warm | Skin warm | 0% - 0.909% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Paraesthesia | Paraesthesia | 0.302% - 0.606% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Acne | Acne | 0.302% - 0.606% |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Hypersensitivity | Hypersensitivity | postmarketing — 0% - 9.9% |  |  |  |  | x |  | x | x | x | x | x | x | x | x | x | x | x | x | 
| Systemic allergic reaction |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | 
| Nasal congestion | Nasal congestion | 0% - 0.606% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Pain of skin | Pain of skin | 0% - 0.606% |  | x | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Apnoea | Apnoea | postmarketing |  |  |  |  |  | x | x |  | x | x | x | x | x | x | x | x | x | x | 
| Coma | Coma | postmarketing |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  | x | 
| Dyspnoea | Dyspnoea | rare |  |  |  |  |  | x | x |  | x | x |  |  |  | x | x | x | x | x | 
| Rash | Rash | postmarketing |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | x | x | x | 
| Glaucoma | Developmental glaucoma | postmarketing |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | 
| Developmental glaucoma | Developmental glaucoma | postmarketing |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | 
| Hypotension | Hypotension | very rare, postmarketing |  |  |  |  |  | x | x |  | x | x | x | x | x | x | x | x | x | x | 
| Body temperature decreased | Body temperature decreased | postmarketing |  |  |  |  |  | x | x |  | x | x | x | x | x | x | x | x | x | x | 
| Hypothermia | Body temperature decreased | postmarketing |  |  |  |  |  | x | x |  | x | x | x | x | x | x | x | x | x | x | 
| Iritis | Iritis | postmarketing, uncommon |  |  |  |  | x |  | x |  |  |  | x | x | x | x | x | x | x | x | 
| Lethargy | Lethargy | postmarketing |  |  |  |  |  | x |  |  | x | x |  |  | x |  |  |  |  | x | 
| Miosis | Miosis | postmarketing |  |  |  |  |  |  | x |  |  |  | x | x | x | x | x | x | x | x | 
| Hypotonia | Hypotonia | postmarketing |  |  |  |  |  | x | x |  | x | x | x | x | x | x | x | x | x | x | 
| Muscle relaxant therapy | Hypotonia | postmarketing |  |  |  |  |  | x | x |  | x | x | x | x | x | x | x | x | x | x | 
| Nausea | Nausea | postmarketing |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  | x | x | x | 
| Pallor | Pallor | postmarketing |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  | x | 
| Blanching |  |  |  |  | x |  |  | x | x | x | x | x | x | x |  |  |  |  |  | 
| Shock | Syncope | very rare, postmarketing |  |  |  |  |  |  | x |  |  |  | x | x | x |  |  |  |  | x | 
| Syncope | Syncope | very rare, postmarketing |  |  |  |  |  |  | x |  |  |  | x | x | x |  |  |  |  | x | 
| Loss of consciousness | Syncope | very rare, postmarketing |  |  |  |  |  |  | x |  |  |  | x | x | x |  |  |  |  | x | 
| Loss of consciousness |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  | 
| Tachycardia | Tachycardia | postmarketing, uncommon |  |  |  |  |  |  | x |  |  |  | x | x | x | x | x | x | x | x | 
| Vasodilation procedure | Vasodilation | postmarketing |  |  |  |  |  |  |  |  |  |  | x | x |  | x | x | x | x | x | 
| Respiratory depression | Respiratory depression | postmarketing |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  | x | 
| Pulmonary function test decreased | Respiratory depression | postmarketing |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  | x | 
| Bradycardia | Bradycardia | postmarketing, uncommon |  |  |  |  |  | x | x |  |  |  | x | x | x | x | x | x | x | x | 
| Eyelids pruritus | Eyelids pruritus | postmarketing, uncommon |  |  |  |  | x |  |  |  |  |  |  | x | x |  |  |  | x | x | 
| Accidental exposure to product | Accidental ingestion | postmarketing |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | 
| Hypertension | Hypertension | very rare |  |  |  |  |  |  | x |  |  |  | x | x |  | x | x | x | x | x | 
| Insomnia | Insomnia | very rare |  |  |  |  |  |  | x |  |  |  | x | x |  | x | x | x | x | x | 
| Anxiety | Anxiety |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  |  | 
| Arthralgia | Arthralgia |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  | 
| Musculoskeletal discomfort | Arthralgia |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  | 
| Myalgia |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  |  | 
| Arthritis | Arthritis |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  | 
| Mental disorder | Mental disorder |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  | 
| Bronchitis | Bronchitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Chest pain | Chest pain |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  | 
| Infection | Infection |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Conjunctival haemorrhage | Conjunctival haemorrhage |  |  |  |  |  |  |  |  |  |  |  | x | x |  | x | x | x | x | x | 
| Corneal oedema | Corneal oedema |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Cough | Cough |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Cyanosis | Cyanosis |  |  |  |  |  |  | x | x |  | x | x |  |  |  |  |  |  |  |  | 
| Diabetes mellitus | Diabetes mellitus |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  | 
| Dyspepsia | Dyspepsia |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Eye disorder | Eye disorder |  |  |  | x |  | x |  | x |  |  |  |  |  | x |  |  |  |  |  | 
| Eye infection | Eye infection |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
| Vitreous floaters | Vitreous floaters |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Cardiac disorder | Cardiac disorder |  |  |  |  |  |  |  | x |  |  |  |  |  | x |  |  |  |  |  | 
| Hordeolum | Hordeolum |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | 
| Hypercholesterolaemia | Hypercholesterolaemia |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Immune system disorder | Immune system disorder |  |  |  |  |  | x |  | x |  |  |  |  |  | x |  |  |  |  |  | 
| Influenza | Influenza |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Iridocyclitis | Iridocyclitis |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | 
| Anterior uveitis |  |  |  |  |  |  |  | x |  |  |  |  |  | x |  |  |  |  |  | 
| Arthropathy | Arthropathy |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  | 
| Osteoarthritis | Arthropathy |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  | 
| Keratitis | Keratitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Mediastinal disorder | Mediastinal disorder |  |  |  | x |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  | 
| Nervous system disorder | Nervous system disorder |  |  |  | x |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  | 
| Osteoporosis | Osteoporosis |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  | 
| Respiratory tract infection | Respiratory tract infection |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | 
| Scotoma | Scotoma |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Sinusitis | Sinusitis |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Swelling | Swelling |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  | 
| Angiopathy | Angiopathy |  |  |  | x |  |  |  | x |  |  |  |  |  | x |  |  |  |  |  | 
| Vitreous detachment | Vitreous detachment |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Burning sensation | Burning sensation |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Cataract | Cataract |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Dry skin | Dry skin |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Skin irritation | Skin irritation |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Vitreous disorder | Vitreous disorder |  |  |  |  |  |  |  |  |  |  |  |  |  |  | x | x | x | x | x | 
| Skin disorder | Unspecified disorder of skin and subcutaneous tissue |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Scab | Scab |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  |  | 
| Myalgia | Myalgia |  |  |  |  |  |  |  |  |  |  |  | x | x |  |  |  |  |  |  | 
| Discomfort | Discomfort |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Eyelid retraction | Eyelid retraction |  |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Peripheral coldness | Peripheral coldness |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Corneal erosion | Corneal erosion |  |  |  |  |  |  |  | x |  |  |  |  |  |  | x | x | x | x | x | 
| Face oedema | Face oedema |  |  |  |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  | 
| Skin discomfort | Skin discomfort |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Rash papular | Rash papular |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Feeling hot | Feeling hot |  |  |  | x |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| Hypoxia | Hypoventilation |  |  |  |  |  |  | x |  |  | x | x |  |  |  |  |  |  |  |  | 
| Respiratory failure | Hypoventilation |  |  |  |  |  |  | x |  |  | x | x |  |  |  |  |  |  |  |  | 
| Hypoventilation | Hypoventilation |  |  |  |  |  |  | x |  |  | x | x |  |  |  |  |  |  |  |  | 
| Blindness | Unspecified visual loss |  |  |  |  |  |  |  |  |  |  | x |  |  |  |  |  |  |  |  | 
	 
 
  Indications
	Information about indications was extracted from the indications and usage sections of the labels.
	
 
	  
	  
		| Side effects: | 17 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 25 | 
|---|
		| Source: | EMA | 
|---|
		 
	  
	  
		| Side effects: | 12 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 36 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
	  
		| Side effects: | 38 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 54 | 
|---|
		| Source: | Medsafe | 
|---|
		 
	  
	  
		| Side effects: | 26 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 38 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 40 | 
|---|
		| Source: | Health Canada | 
|---|
		 
	  
	  
		| Side effects: | 47 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 48 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 56 | 
|---|
		| Source: | medicines.org.au | 
|---|
		 
	  
	  
		| Side effects: | 69 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 70 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 68 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 69 | 
|---|
		| Source: | FDA | 
|---|
		 
	  
	  
		| Side effects: | 75 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
  
 
  
	Color scheme:
	  
	  standard – alternative
	  
	
	
|  |  | 100% | 
|  |  | 75% | 
|  |  | 50% | 
|  |  | 10% | 
|  |  | frequent (1% to 100%) | 
|  |  | infrequent (0.1% to 1%) | 
|  |  | rare (<0.1%) | 
|  |  | postmarketing | 
|  |  | 0% | 
|  |  | no frequency information | 
|  |  | not found on label |